Journal: The New England journal of medicine
The publication provides a comprehensive review of recent advances in cancer immunotherapy, focusing on the mechanisms of immune checkpoint inhibitors and their clinical applications.
It discusses the successes and challenges of current therapies, including resistance mechanisms and adverse effects.
The article also highlights emerging strategies to enhance immunotherapy efficacy, such as combination treatments and personalized approaches.
These efforts aim to improve patient outcomes across various cancer types.